AN INTRODUCTION FOR CLINICIANS
VOLO™ Scores translate comprehensive patient data — vitals, bloodwork, and physical measures — into clear, intuitive health scores that make it easier for clinicians to explain and monitor long-term health status and risk.
Discover the power of VOLO ScoresFor Clinicians
Your time is valuable, and distilling your patient's information into actionable insights based on their 10 to 15 year health outlook is key. Our system gives you a data-driven long-term view of patient health—helping you elevate care and patient understanding.
Our advanced data science approach helps patients grasp where they are today in relation to their long-term health, why it matters, and how recommended actions can help them improve. So clinicians can focus on behavior modification to strengthen long-term health.
the challenge
Patients are generating more data than ever — but turning these data into insight takes considerable time and complex analysis
Without simplified and trackable metrics, behavior modification is a challenge.
Today you interpret patient lab tests, physical measures, vitals, health history, family health history, wearable data, and other test results — but lack concise interpretation.
Even with extended visits, synthesizing complex data are inefficient.
"Normal" doesn't always mean optimal, especially across all health domains.
VOLO™ Scores use predictive models to translate complex, multi-source data into an easy-to-understand view of your patients' long-term health across key health domains.
Give clinicians and patients a shared, easy-to-understand framework for discussing long-term health risks, priorities, and next steps.
Identify which health domains may need attention, helping care teams focus recommendations where they can create the greatest long-term health impact.
Track how scores and health domains evolve, making it easier to monitor improvement and adjust long-term health strategies over time.
The Science
What if we could provide predictive models that synthesize complex health data from multiple sources into clear, easy to understand scores and insights — empowering clinicians to efficiently communicate the tradeoffs of potential lifestyle decisions?
The data science behind VOLO™ Scores results in a robust health calculator, providing a comprehensive view for clinicians to evaluate and ultimately guide recommended interventions to improve patients’ long-term health.
Unlike most health scores, VOLO™ Scores take a holistic view of multiple health domains in one view. The healthspan overview is the 10-15 year roadmap for clinicians to assess each health domain, permitting efficient focus, drill downs, and comparison to prior dates.
Standard lab ranges tell clinicians what's normal, typically regardless of age and sex. VOLO™ Modeled Ranges use advanced modeling to determine age and sex-adjusted healthy ranges for each biomarker value across key health domains - along with its impact on VOLO™ Scores, giving clinicians a clearer picture of what biomarker values are influencing long-term health.
Our benchmarks are grounded in real-world health patterns produced by our advanced predictive models that have been trained on large, diverse population datasets — including healthy and unhealthy individuals.
When you recognize a pattern in a patient's data, you're drawing on every case you've seen before. Our machine learning system does the same — except it has been trained on the relationships between billions of data points across enormous, diverse populations.
VOLO™ Scores translate this into a single, intuitive view of each patient's long-term health trajectory — distilling billions of data relationships into clear and meaningful metrics you need to make every conversation more informed and every lifesteyle decision more precisely timed.
"Instead of giving an output based on a fixed set of rules [heuristic model], our models are trained on relationships from large numbers of real-world examples."
VOLO™ Scores were developed through collaboration and consultation with physicians, longevity practitioners, and researchers across medical and wellness communities, ensuring the approach reflects evidence-based research — not just the philosophy of a few individuals.
This has the potential to significantly reduce the cognitive and time burden involved in compiling large amounts of patient biomarker and physiology data, allowing physicians to spend more time focused on long-term outlooks, patient strategy, and individualized care.
This has the potential to significantly reduce the cognitive and time burden involved in compiling large amounts of patient biomarker and physiology data, allowing physicians to spend more time focused on long-term outlooks, patient strategy, and individualized care.
Dr. Kevin Taylor, MD
While routine lab work just gives you a list of numbers, VOLO™ Health can give a clear data-driven precise story about your long-term health. VOLO™ Scores are a new clinical language. They turn raw data into predictive intelligence empowering both patients and clinicians to have a sharper tool for preventing disease, not just treating it after the fact.
While routine lab work just gives you a list of numbers, VOLO™ Health can give a clear data-driven precise story about your long-term health. VOLO™ Scores are a new clinical language. They turn raw data into predictive intelligence empowering both patients and clinicians to have a sharper tool for preventing disease, not just treating it after the fact.
Dr. Yousif A-Rahim, Gastroenterologist
Being measured against people like me – same age, gender and health profile (not just standard lab ranges) – really resonated. My scores showed I was 4.5 times more likely than others like me to experience metabolic health issues (Type 2 diabetes). That was a real wake-up call. The VOLO Scores made me focus on lowering my A1c. I knew exactly what to work on, and I lowered my long-term risk from 4.5 times higher than average to below average in 6 months.
Being measured against people like me – same age, gender and health profile (not just standard lab ranges) – really resonated. My scores showed I was 4.5 times more likely than others like me to experience metabolic health issues (Type 2 diabetes). That was a real wake-up call. The VOLO Scores made me focus on lowering my A1c. I knew exactly what to work on, and I lowered my long-term risk from 4.5 times higher than average to below average in 6 months.
Kirsten Feldman, VOLO Health Client
The data science team behind the VOLO™ Score are extremely talented data scientists who have been working for 25 years, some of them, using data science in healthcare.
The data science team behind the VOLO™ Score are extremely talented data scientists who have been working for 25 years, some of them, using data science in healthcare.
Dr. Randy Axelrod, VOLO Health Chief Medical Officer
Volo Health gives physicians like myself the ability to move beyond just simply identifying long-term risk factors and instead show patients a more complete picture of how their biomarkers may influence long-term health and longevity. It helps turn complex data into meaningful, personalized insight and I believe that’s one of the missing links in modern preventive medicine. Before, if I say to my patients you should really exercise…they say, okay… “why”? So now thanks to VOLO Health I have a way to say this is “why”, and if you do this, then these are the parameters that can change to lower your future health risk and increase your longevity.
Volo Health gives physicians like myself the ability to move beyond just simply identifying long-term risk factors and instead show patients a more complete picture of how their biomarkers may influence long-term health and longevity. It helps turn complex data into meaningful, personalized insight and I believe that’s one of the missing links in modern preventive medicine. Before, if I say to my patients you should really exercise…they say, okay… “why”? So now thanks to VOLO Health I have a way to say this is “why”, and if you do this, then these are the parameters that can change to lower your future health risk and increase your longevity.
Dr. Lorne Stitsky, Board Certified American Osteopathic Family Physician
For someone who's diabetic or pre-diabetic — the age comparison by organ system makes sense. Understanding the impact of LDL and other biomarkers and how they are impacting age scores is very impactful.
For someone who's diabetic or pre-diabetic — the age comparison by organ system makes sense. Understanding the impact of LDL and other biomarkers and how they are impacting age scores is very impactful.
Dr. Orlando Cedeno, DPM
Early Access
Experience how turning data into clarity can transform patient engagement and long-term health.
Biomarker strength indicates how strongly a biomarker correlates to a particular health domain, based on VOLO Health's models. Values range from 1 (weakest) to 10 (strongest). This lets you see at a glance which biomarkers contribute most to each domain.
No. The VOLO Score is not a diagnostic tool and does not replace clinical diagnosis of a patient's current health status. It provides a long-term health outlook and supports prevention, allowing clinicians and patients to intervene early to improve long-term health.
Genetic data is not yet fully integrated into the standard VOLO Score, but it is actively in development and represents the next major evolution of the platform.
We can provide VOLO Scores with a limited set of blood biomarkers because we impute missing biomarkers from large population data — though the more biomarkers used, the better. See the list of biomarkers used to generate VOLO Scores and their prediction strength, and the 5 biomarkers we recommend adding to blood tests.
Individual lab values are typically evaluated against population reference ranges — flagging what's abnormal but offering little insight into how those values interact or what they mean for a patient's long-term trajectory. The VOLO Score analyzes multiple biomarkers simultaneously across 11 health domains, accounting for age and sex, and surfaces the combinations quietly driving long-term risk.
VOLO Scores are generated from bloodwork, vital signs, and biometric data. Because biomarkers change over time, regular updates are essential. Every 3 to 6 months is the recommended cadence for most patients; those tracking specific interventions may draw more frequently.
VOLO Scores do the heavy lifting before the visit. Rather than synthesizing raw lab values one by one, you arrive with a clear visual snapshot across 11+ domains, with the highest-priority domains and biomarker relationships already identified. This shifts the conversation from data explanation to behavior change.
We are onboarding clinicians for the Clinician Pilot program. Contact our team to learn more about the program.
